Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

217 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03691610

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Alabama Clinical Therapeutics Site Number : 8400036 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates Site Number : 8400009 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix Site Number : 8400013 Phoenix, Arizona, United States
  • Emmaus Research Center, Inc Site Number : 8400019 Anaheim, California, United States
View all 47 locations
View Trial Details
Completed

Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults

NCT04502693

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Bell Gardens, California, United States
View all 112 locations
View Trial Details
Completed

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03673462

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Birmingham Pediatric Associates-Site Number:8400049 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates-Site Number:8400034 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix-Site Number:8400043 Phoenix, Arizona, United States
  • Northwest Arkansas Pediatric Clinic-Site Number:8400042 Fayetteville, Arkansas, United States
View all 69 locations
View Trial Details
Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

NCT03632720

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Investigational Site Number :8260024 Newquay, Cornwall, United Kingdom
  • Investigational Site Number :8260009 Penzance, Cornwall, United Kingdom
  • Investigational Site Number :8260013 Torpoint, Cornwall, United Kingdom
  • Investigational Site Number :8260010 Exeter, Devon, United Kingdom
View all 13 locations
View Trial Details
Completed

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

NCT03630705

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Investigational Site Number :4840001 Acapulco de Juárez, Guerrero, Mexico
  • Investigational Site Number :4840002 Mexico City, Mexico
  • Investigational Site Number :4840003 Tlaltizapán, Morelos, Mexico
  • Investigational Site Number :6431018 Gatchina, Leningradskaya Oblast', Russia
View Trial Details
Completed

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

NCT03493919

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Sydney, New South Wales, Australia
  • GSK Investigational Site Adelaide, South Australia, Australia
  • GSK Investigational Site Geelong, Victoria, Australia
  • GSK Investigational Site Melbourne, Victoria, Australia
View Trial Details
Completed

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

NCT01725217

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • Federal State Budgetary Institution 'State Scientific Center 'Institution of Immunology' of the Russian Federal Biomedical Agency' Kashirskoye Highway, Moscow, Russia
  • Institution of the Russian Academy of Sciences "Scientific Center for Children Health RAMS" Lomonosovskiy Avenue, Moscow, Russia
  • Federal Budgetary Institution of Science 'St-Petersburg Scientific-Research Institution of Epidemiology and Microbiology by name of Pasteur' Mira Street, Sankt-Peterburg, Russia
  • Federal State Institution 'Scientific-Research Institution of Children's Infections of the Russian Federal Biomedical Agency' Prof.Popova Street, Sankt-Peterburg, Russia
View Trial Details
Completed

The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults

NCT03798574

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • The Children's Hospital at Westmead Westmead, New South Wales, Australia
  • Women's and Children's Hosptial Adelaide, South Australia, Australia
  • Monash Children's Hospital, Melbourne Clayton, Victoria, Australia
  • Perth Children's Hospital Nedlands, Western Australia, Australia
View Trial Details

Related conditions